Use of On-Q Pump for Pain Post C-Section
Completed · Phase 4
Conditions studied: Pain
In brief
The main purpose of this study is to examine if pain levels treated with intrathecal (IT) preservative-free morphine (PFM) after a cesarean section improve with the additional use of continuous subfascial wound infiltration with ropivacaine using the OnQ® elastomeric pump system.
Key facts
- Study ID
- NCT02579629
- Run by
- Emory University
- People needed
- 64
- Starts
- 2015-07-01
- Expected to finish
- 2019-07-25
- Last updated by the study team
- 2020-10-14
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Female patients at Emory University Hospital Midtown undergoing non-emergent, scheduled or unscheduled first, second or third Cesarean sections
- Patients who are American Society of Anesthesiology (ASA) Class I-III
- Patients are at least 34 weeks pregnant
- Patients to receive spinal anesthesia for their procedure
- Patients who are 18 years of age or older
- Patient willing and able to provide written informed consent
You may not qualify if…
- Patients with 3 or more prior Cesarean sections
- Patients undergoing emergent cesarean section with or without general anesthesia
- Patients with known allergy to morphine, ketorolac, and/or amide local anesthetics
- Patients who will not receive spinal anesthesia
- Patients who are less than 34 weeks pregnant
- Patients with significant maternal cardiac, liver or renal disease
- Patients with maternal history of narcotic abuse or dependency
- Patient with pre-operative fever (>100.4 degrees F)
- Patients less than 18 years old
Where it is running
- Emory University Hospital Midtown — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.